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Background: To evaluate early, mid and long term efﬁcacy of laparoscopic sleeve gastrectomy as a
deﬁnitive management of morbid obesity and to study factors that may predict its success.
Materials and methods: A retrospective study was conducted by reviewing the database of patients who
underwent LSG as a deﬁnitive bariatric procedure, from April 2005 to March 2013. Univariate and
multivariate analysis were performed.
Results: 1395 patients were included in this study. Mean age was 33 years and women:men ratio was
74:26. The mean preoperative BMI was 46 kg/m2. Operative time was 113  29 min. Reinforcement of
staple line was done only in 447 (32%) cases. 11 (0.79%) cases developed postoperative leak, with total
number of complications 72 (5.1%) and 0% mortality. Percentage of excess weight loss (%EWL) was 42%,
53%, 61%, 73%, 67%, 61%, 59% and 57% at 6 months, 1e7 years. Remission of diabetes (DM), hypertension
(HTN) and hyperlipidaemia (HLP) occurred 69%, 54% and 43% respectively. 56 (4%) patients underwent
revision surgery, for insufﬁcient weight loss (n ¼ 37) and severe reﬂux symptoms (n ¼ 19). Mean follow
up was 76  19 (range: 6e103) months. Smaller bougie size and leaving smaller antrum were associated
with signiﬁcant %EWL. Bougie 36F remained signiﬁcant in multivariate analysis.
Conclusion: This study supports safety, effectiveness and durability of LSG as a sole deﬁnitive bariatric
procedure. Smaller bougie size and shorter distance from pylorus were associated with signiﬁcant %EWL.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Laparoscopic sleeve gastrectomy (LSG) was ﬁrst used as 1st
stage of two staged bariatric surgery for those with high surgical
risk severely obese patients (BMI 60 kg/m2). In the past few years,
on the basis of several studies, LSG is becoming a sole bariatric
procedure due to its effectiveness on weight loss and co-
morbidities resolution [1e4].
LSG is a restrictive procedure in which up to 80% of the stomach
is vertically resected leaving a gastric tube or conduit preserving
the vagi and pylorus. LSG is proved to have a weight loss effect
within the range between gastric banding and bypass surgery.
Moreover, it is a simple procedure with low morbidities and
negligible long term nutritional deﬁciencies [5,6]. We conductedEllatif).
by Elsevier Ltd. All rights reservedthis retrospective study to review our experience with application
of LSG as a deﬁnitive procedure for morbidly obese patients.2. Materials and methods
Our study is a retrospective multi-center study through
reviewing the database of the morbidly obese patients admitted at
our institutions, (Jahra Hospital-Kuwait, King Faisal Hospital- KSA,
andMansoura University Hospital- Egypt) who underwent LSG as a
deﬁnitive bariatric procedure from April 2005 throughMarch 2013.
Patients with age 18e65 years, BMI >40, or >35 with co-
morbidities after failure of many dietetic regimen, acceptable
levels of surgical risk, a clear understanding of the surgery and its
impact on patient’s life were included in the study after having an
informed signed consent. We excluded patients with prohibitive
surgical risk, indications of lack of compliance with perioperative
regimen, uncontrolled alcohol or drug abuse, uncontrolled
depression or other mental disorders, and lack of family support or
signiﬁcant discord within the family about the planned surgery..
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amination to assess the co-morbidities. Diagnostic workup includes
gastroscopy, abdominal ultrosonography, X-ray chest ﬁlm, electro-
cardiogram, complete blood count, coagulation proﬁle, thyroid
proﬁle, electrolytes, blood urea nitrogen (BUN), creatinine, and
evaluations of liver functions and lipid levels. Consultation with
cardiologists, pulmonologists and anesthetists was done. Patients
received one injection of 1st generation cephalosporin during in-
duction and deep vein thrombosis prophylaxis (DVT) in the form of
enoxaparin and elastic stockings.Fig. 1. 1395 patients from April 2005 through March 2013.3. Surgical technique
The greater curve was devascularized using Harmonic scalpel or
LigaSure devices going up to angle of Hiss. Distance proximal from
the pylorous to the 1st staple ﬁring was formally measured by a
ruler or a length of suture, (2e4 cm in 586 and 5e7 cm in 809
patients). A conduit of stomach was tailored over 36 Fr bougie in
837 and 44 Fr bougie in 558 cases, using endo GIA linear staplers
startingwith 1e2 green cartridges at the antrum and 2e4 blue ones
at the body and the fundus.
At the early stage of study, the staple line was reinforced (447
cases) to prevent leakage and bleeding. Running stitch reinforce-
ment was used in 307 cases starting from gastroesophageal junc-
tion downward and bovine pericardium (Peri-strips Dry [PSD])
reinforcement was used in 140 cases. In the remaining cases we
stopped using reinforcement. Integrity of the staple line was
checked intraoperatively by injecting a methylene blue before
going to remove the bougie. Redivac drain (in 319 cases) was left
behind at the left hypochondrial space after retrieval of the resec-
ted part that was sent for histopathology. All 10 mm port open-
ings were closed routinely using polyglycolic acid suture 1 for
sheath closure then the port sites were inﬁltrated with marcaine
after skin closure. All patients were operated by operative teams
who are experienced in laparoscopic bariatric surgery. All opera-
tions were completed laparoscopically.
79 (5.6%) patients had concomitant cholecystectomy for symp-
tomatic gall bladder stones, and 59 patients had hiatoplasty for
hiatus hernia (stitching both diaphragmatic crura by means of 2 or
3 non-absorbable stitches leaving at least 1 cm space for the
esophagus with a bougie inside to avoid postoperative dysphagia),
and 56 patients with umbilical hernia had suture repair by the
conventional approach.
On the 1st postoperative day (POD), leakage was further
checked by gastrografﬁn meal study, then patients were encour-
aged to start oral ﬂuid for 4 days and progress to semi-solid for
further 3 weeks then solid foods were allowed after the 4th week,
according to the dietician instructions. Anticoagulant was
continued while staying in hospital and at home for 2 weeks till he/
she is full ambulant. Patients were discharged if they were going
well and advised to take multivitamins and proton pump inhibitor
for one month and when needed thereafter.
The 1st follow up visit was one week later to check wounds and
any complications. Multivitamins and calcium supplementations
were prescribed for all patients. Ursidiol 300 mg twice daily was
prescribed as a gall stone prophylaxis for 6 months to patients with
intact bladder. Next follow up visits were scheduled every 3months
in the 1st year, every 6 months in the 2nd year, and yearly there-
after. Laboratory investigations for protein, mineral and vitamin
deﬁciency was done yearly. Mean follow up duration was 76  19
(range: 6e103) months.
Patients’ data were collected into a data sheet for statistical
purpose including clinical, radiologic, laboratory, operative and
postoperative ﬁndings.3.1. Statistical analysis
The statistical analysis of the data in this study was done using
the SPSS version 10. For continuous variables, descriptive statistics
were calculated and were reported as mean  SD. Categorical
variables were described using frequency distributions. The Stu-
dent’s t- test for paired samples was used to detect differences in
the means of numerical variables, Chi-square test or Fisher’s exact
test (when necessary) was used for qualitative variables. P values
>0.05 were considered to be signiﬁcant. Signiﬁcant variables were
entered into a logistic regression model to determine independent
signiﬁcant variables. They were expressed as odds ratios (OR) with
their 95% CI.
4. Results
1419 patients underwent LSG as a deﬁnitive bariatric procedure
at our institutes. 1395 patients were included in this study as 24
patients were lost for follow up. 1395 (100%) patients were fol-
lowed up for 6 months, 1339 (96%) patients for 1 year, 1156 (83%)
for 2 years, 1089 (78%) patients for 3 years, 983 (70%) patients for 4
years, 859 (62%) patients for 5 years, 731 (53) patients for 6 year,
519 (37%) patients for 7 years, and 307 (22%) patients for 8 years
(Fig.1). Mean agewas 33 7 (range: 18e65) years andwomen:men
ratio was 74:26. BMI was 46  9 (range: 40e70) kg/m2, with mean
body weight 109  25 (range: 100e178) kg. Diabetes mellitus (DM)
was found in 41%, hypertension (HTN) in 57%, obstructive sleep
apnea syndrome (OSAS) in 22% cases, degenerative joint disease
(DJD) in 32%, and hyperlipidemia (HLP) in 43% patients. All opera-
tions were completed laparoscopically with mean operative time
113  29 (range: 79e139) minutes. Time to resume oral intake
was1.7  0.8 (range: 0.9e2.9) days, and hospital stay was 3.9  1.7
(2.1e25) days (Table 1).
Co-morbidities were assessed every follow up visit and
improvement was considered if the dosage of medication were
reduced or patient needed fewer drugs to control his/her disease.
Resolution of disease was considered if patient is no longer
requiring medication. At 3 years, DM, HTN, OSAS, DJD, and HLP
were remitted in 69%, 54%, 51%, 61% and 43% respectively.
5. Intraoperative complications
Bleeding from short gastric vessels at the upper pole of spleen
occurred in 3 patients that was solved laparoscopically and spleen
was preserved. 35 patients had bleeding at the staple line that was
controlled sufﬁciently by endo-clips or reinforcing stitches. One
patient had left liver lobe injury during introduction of the
Table 1
Patients’ characteristics.
Variable N ¼ 1395
Age (years) 33  7 (range: 18e65 years)
Sex (Women:Men %) 74:26
Preoperative BMI (kg/m2) 46  9 (range: 40e70 kg/m2)
Preoperative Weight (kg) 109  25 (range: 100e178) kg
Operative time (min) 113  29 (range: 79e139) minutes
Oral intake (days) 1.7  0.8 (range: 0.9e2.9) days
Hospital stay (days) 3.9  1.7 (2.1e35) days
Follow up (months) 46  19 (range: 6e103) months
BMI body mass index.
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son’s retractor. 28 patients showed intraoperative staple line leak
diagnosed by methylene blue that was treated by over-sewn
stitches.6. Postoperative complications
72 (5.1%) cases had complications with 0% mortality. 11 (0.78%)
patients had leak; all of them had leakage from gastroesophageal
junction. 6 patients had acute leak (within 7 days of the primary
procedure). Five of them were treated by relaparoscopy, re-suture
of the staple line, abdominal lavage, and abdominal drains. The
6th patient had leakage that was diagnosed on the 4th POD with
signs of sepsis despite of the initial gastrografﬁn study was nega-
tive. Re-laparoscopy and thorough peritoneal lavage was done with
stitching of the site of leakage and intraoperative methylene blue
test was negative. 2 days later, drain showed evidence of leakage.
An intraluminal wallstent was inserted endoscopically. The pa-
tient’s general condition started to improve ﬁnally and was dis-
charged home 25 days later.
Four cases with early leak (1e6weeks of the primary procedure)
were managed successfully with endoscopic wallstent and percu-
taneous drainage. The 11th patient had late leak (after 6 weeks of
the primary procedure). This patient was managed by endoscopic
wallstent and percutaneous drainage. Gastrografﬁn study on the
5th day showed leakage which was unsuccessfully treated by one
more stent at the same day. His problem has been ﬁnished by
gastrectomy and oesophagojejunostomy.
35 patients had repeated admissions for vomiting, nausea, and
dehydration. 13 patients were readmittedwith persistent vomiting,
nausea, and dehydration, upper endoscopy and contrast study
revealed no pathology. They improved on intravenous ﬂuid (IVF)
and were discharged home. 5 patients had more readmissions with
3e5 months interval with the same picture. Repeated endoscopy
revealed ulcer on the staple line and they were kept on proton
inhibitor for 3 months with resolution of their symptoms. 6 pa-
tients had repeated admissions with the same picture and every
time they underwent investigations which always came normal.
They were improved on oral domperidone suggesting that the
underlying cause was gastric dysmotility. Upper gastrointestinal
contrast study showed narrowing at the site of incisura in 4 pa-
tients which was treated by 2e3 sets of endoscopic dilatation. The
other 7 cases were diagnosed by endoscopy as severe reﬂux disease
and they were treated by proton pump inhibitor.
Total number of patients developed de novo GERD after sleeve
gastrectomy was 159 (11.4%) patients during the 1st year. These
declined signiﬁcantly to 29 (2%) after 4 years of follow up. They
need proton pump inhibitor for long period to treat their severe
reﬂux symptoms.
Five patients had pulmonary embolism. They were treated
successfully by anticoagulant. Seven patients had pneumonia andwere treated medically. Another 9 patients had retrieval wound
infection which was treated medically. Five patients had retrieval
port-site hernia andweremanaged bymesh hernioplasty 6months
later.
7. Weight loss results
Postoperative BMI was 41  9, 39  7.2, 36  6.6, 33  5.6,
29  4.7, 30  5.9, 31  6 and 31  7.2, and percentage of excess
weight loss (%EWL) was 42%, 53%, 61%, 73%, 67%, 61%, 59% and 57%
at 6 months, 17 years, respectively. 37 patients showed inadequate
weight loss (<30e50% of %EWL at least 2 years out) or signiﬁcant
weight regain that necessitate revisional surgery (laparoscopic
resleeve was done in 19 patients, laparoscopic banding in 13 pa-
tients, and laparoscopic gastric bypass in 5 patients) (see Table 2).
We found relationship between some technical points and
weight loss result. When stratifying the weight loss outcome (%
EWL) by bougie size (36 versus44Fr) and distance form pylorus,
we found that the bougie size of 36 Fr and shorter distance
from pylorus did not result in signiﬁcantly greater %EWL in the
early postoperative period up to the 3rd year (47,56,62,69 Vs
39,51,59,64; P > 0.5) (43,55,61,67, Vs 39,48,60,58; P > 0.5) respec-
tively (Tables 3,4). However, univariate analysis demonstrated that
those with smaller bougie and shorter distance from pylorus
maintained weight loss in the long term (71,74,67,63 Vs 57,53,51,50
with P¼ 0.001) (71,73,72,69 Vs 56,53,51,50; P¼ 0.001) respectively.
Big sizing Bougie and longer distance from pylorus result in greater
weight regain in the long term, 29 (3.5%) Vs 8 (1.4%) P ¼ 0.001.
These signiﬁcant variables identiﬁed in univariate analysis were
further analyzed in multivariate analysis. Smaller bougie (36F)
remained independent signiﬁcant long term pridctors of success
for weight loss and weight regain in the multivariate analysis
(Table 5).
Reinforcement of staple line was done only in 447 (32%) cases
for fear of leakage and bleeding complications. We had 0.67% (3 out
of 447) leakage rate in the patients with reinforcement versus to
0.84% (8 out of 948) in the patients without reinforcement sug-
gesting that reinforcement of the staple line has no value (Table 6).
Neither the distance of the ﬁrst stapler from the pylorus nor the
caliber of the bougie was related to postoperative complications
(Tables 3 and 4).
56 (4%) patients underwent revision surgery, 37 patients were
revised for insufﬁcient weight loss and/or weight regain (<50% %
EWL) and severe reﬂux symptoms (n¼ 19). Resleevewas done in 19
patients, laparoscopic banding in 13 patients, and laparoscopic
gastric bypass in 24 patients (for weight loss, n ¼ 5 and GERD,
n ¼ 19). All were successful laparoscopically with minimal com-
plications. The mean interval between the two procedures was
almost 32 months.
Histology of the resected segment was normal in 429 (30.7%).
Chronic follicular gastritis was present in 407 (29.2%), chronic non-
speciﬁc gastritis in 350 (25.1%), and chronic lymphoid gastritis in 81
(5.8%). Helicobacter Pylori was found in 128 (9.2%).
8. Discussion
After Gagner has performed LSG in 1999 as a 1st stage in super-
obese persons, several papers were published conﬁrming the good
results of this procedure. At present, LSG is well accepted as a
deﬁnitive bariatric procedure with low morbidities and acceptable
weight loss results. Before we started this operation in 2005, there
were 2 bariatric operations available for our patients (gastric
banding and gastric bypass). Thereafter, it became the default
procedure offered to our patients. Most of our patients were in the
3rd decade, women were nearly triple number of men (74:26). The
Table 2
Weight loss result.
Variable Postop. BMI (Kg/m2) % EWL
6 months 41  9 42%
1 year 39  7.2 53%
2 years 36  6.6 61%
3 years 33  5.6 73%
4 years 29  4.7 67%
5 years 30  5.9 61%
6 years 31  6 59%
7 years 31  7.2 57%
Percentage of excess weight loss (%EWL).
Table 3
Value of caliber of the bougie.
Variable 36 Fr 837 (60%) 44 Fr. 558 (40%) P value
EWL % at6 m. 47  19 39  14 0.3
EWL % at 1 year 56  19.7 51  19 0.3
EWL% at 2 years 62  17 59  23 0.8
EWL % at 3 years 69  25 64  25 0.34
EWL % at 4 years 71  27 57  25 0.001
EWL % at 5 years 74  29 53  21 0.001
EWL % at 6 years 67  28 51  19 0.001
EWL % at 7 years 63  21 50  17 0.001
Weight regain 29 (3.5%) 8 (1.4%) 0.001
Complications 45 (5.37%) 27 (4.83%) 0.75
Leak 7 (0.83%) 4 (0.71%) 0.26
GERD 98 (11.7%) 68 (12.1%) 0.75
Vomiting 21 (2.5%) 14 (2.5%) 0.52
Percentage of excess weight loss (%EWL), GERD, gastroesophageal reﬂux.
Table 5
Multivariate analysis of signiﬁcant variables.
Variable OR 95% CI P value
EWL % at 4 years
- Distance from pylorusa 15.17 9.103e31.349 0.271
- Caliber of bougieb 23.45 14.291e53.923 0.0001
EWL % at 5 years
- Distance from pylorus 19.23 12.135e34.239 0.372
- Caliber of bougie 27.29 15.984e41.274 0.0001
EWL % at 6 years
- Distance from pylorus 17.9 9.105e33.9542 0.072
- Caliber of bougie 26.25 14.193e39.927 0.0001
EWL % at 7 years
- Distance from pylorus 17.98 11.165e38.654 0.093
- Caliber of bougie 28.34 17.025e43.367 0.0001
Weight regain
- Distance from pylorus 25.39 13.995e42.274 0.851
- Caliber of bougie 9.037 5.134e21.956 0.0001
OR; odd ratio, CI; conﬁdence interval.
a 2e4 cm from pylorus compared with 5e7 cm as the reference category.
b 36F bougie compared with 44F bougie as the reference category.
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above 50.
GERD symptoms appeared immediately in the majority of pa-
tients which can be explained by alteration of the natural anti-
reﬂux mechanisms such as angle of His and phrenoesophageal
membrane. Himpens et al. [6] found incidence of 21.8% of patients
had GERD symptoms at 1 year follow up compared to 3.1% at 3 year,
suggesting that GERD would be a temporary problem after LSG. In
our study, 11.4% patients had reﬂux symptoms at 1 year follow up,
which decreased progressively till reach 2% at 4 years. Conversion
from LSG to gastric bypasswas necessary in 19 (1.4%) of our patients
de to persistence of reﬂux symptoms after a mean interval of 32
months following LSG. Crookes [7] reported conversion from LSG to
bypass surgery with complete resolution of symptoms in 11 pa-
tients who had persistent GERD symptoms.
Incidence of leakage in the literature is between 0% and 5.7% [8e
10], with high rate reported by Stroh et al. [11] in their nationwide
survey in Germany. They showed leakage rate of 7%, with totalTable 4
Value of distance from the pylorus.
Variable 2e4 cm 586 (42%) 5e7 cm 809 (58%) P value
%EWL at 6 m 43  19 39  14 0.47
%EWL at 1 year 55  19.7 48  16 0.35
%EWL at 2 years 61  17 60  19 0.57
%EWL at 3 years 67  23 58  21 0.35
%EWL at 4 years 71  19 56  25 0.001
%EWL at 5 years 73  27 53  23 0.001
%EWL at 6 years 72 þ 21 51  17 0.001
%EWL at 7 years 69  19 50  18 0.001
Weight regain 9 (0.8%) 28 (3.5%) 0.001
Complications 27 (4.6%) 45 (5.5%) 0.65
Leak 5 (0.85%) 6 (0.74%) 0.18
GERD 68 (11.6%) 91 (11.2%) 0.75
Vomiting 14 (2.38%) 21 (2.59%) 0.72
Percentage of excess weight loss (%EWL), GERD, gastroesophageal reﬂux.complication rate 14% andmortality rate 1.6%. They even concluded
that LSG is not a safe procedure unlike others have reported. In our
series, 11 (0.78%) had leakage. We had 0.67% (3 out of 447) leakage
rate in the patients with reinforcement versus to 0.84% (8 out of
948) in the patients without reinforcement suggesting that rein-
forcement of staple line is of no value. The same result was reported
by others [12,13]. On the opposite, Ser et al. [14] found that staple-
line reinforcement is strongly recommended for laparoscopic
sleeve gastrectomy to decrease complications. We also found that
there was no association between reinforcement and bleeding
complication.
The most common site for post-sleeve leakage is the gastro-
esophageal junction. Increased intra-luminal pressure due to
decreased stomach compliance after resection of the fundus is the
more accepted explanation. The other reported site for leakage is
the antrum with different explanation that the increased gastric
wall thickness at that region (mean 3.1 mm) could have compro-
mised the full closure of the staples, even the longest available ones
(green) [15].
Bellanger and Greenway believe that there are two main tenets
to adopt in order to minimize leaks. First, and of utmost impor-
tance, is to avoid creating a physiologic stricture at the incisura
angularis, and second, avoid stapling too close to the esophagus in
the area of the cardia [16]. In addition, we advocate longer time for
compression of the gastric tissue with the stapling device, thus
promoting proper staple formation and reducing both serosal
trauma and bleeding.
Majority of our patients did not require a second stage operation
because they had satisfactory results with their LSG surgery
regarding the weight loss effect and improvement or resolution of
their co-morbidities, in addition to the negligible nutritional com-
plications they had. During the follow up period, 29 (2%) patientsTable 6
Value of suture line reinforcement.
Variable With 447 (32%) Without 948 (68%) P value
Operative time 135  23 min. 91  17 min. 0.001
Postop. morb. 21 (4.7%) 51 (5.4%) 0.37
Leak 3 (0.67%) 8 (0.84%) 0.83
Luminal hge 0 0 e
Staple line hge 9 (2%) 26 (2.7%) 0.17
Postop, postoperative; morb., morbidity hge, hemorrhage.
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supplement. Level of vitamin D, folate, and calcium remained
within their normal range. Deﬁciency of vitamin B12 after LSG may
be explained by inadequate vitamin B12 uptake due to the lower
production of hydrochloric acid which is important to release
bound vitamin B12 in food [17]. Prasad et al. reported 2.7% patients
with deﬁcient vitamin B12 level after LSG [18].
In terms of weight loss, we reported excellent responses. 37
(2.6%) patients required a second operation due to insufﬁcient
weight loss and/or weight regain. Our results are comparable to
other reports [14,19e21]. We found relationship between some
technical points and the weight loss results. Close distance of the
staple line to the pylorus and application of a thinner bougie during
the calibration of the stomach tube were signiﬁcantly related to the
% EWL in the long term (P ¼ 0.001) without signiﬁcant difference
regarding the postoperative complications. Gagner et al., on the
contrary, reported an inverse relationship between bougie size and
leak rate and recommended a bougie size between 50 and 60
French to minimize this complication [22].
In comparison to the overall published mortality associated to
laparoscopic gastric bypass (LRYGB) of 0.5% or bilio-pancreatic
diversion (BPD) of 1.1%, we observed a 0% mortality rate among
1395 patients who underwent laparoscopic sleeve gastrectomy.
This reﬂects the high safety of this procedure. Complication rate
(5.1%) was also lower than the overall published complication rate
following LRYGB or BPD (10e20%) [22e24].
Points of strength of the present study include the relatively
large number of patients it involves, multicenter, and its long follow
up period. Despite these study’s strength points, its major limita-
tions was the characteristic of retrospective studies as it lacks the
capability of randomization and precise categorization of patients
regarding how precisely far from the pylorus and also how big
should be the bougie size which were the main study factors. We
recommend for a prospective randomized study with the same
strength points of the present study to answer these puzzled
questions.
9. Conclusion
LSG is safe and effective as a sole deﬁnitive bariatric proce-
dure with less complication rate and no mortality. It is effective
for co-morbidities resolution. We noticed no signiﬁcant beneﬁt
from the staple line reinforcement. Close application of the staple
line to the pylorus and calibration of the gastric tube around
bougie 36 Fr were signiﬁcantly correlated to the good results of
%EWL without signiﬁcant difference regarding the postoperative
complications. Further prospective studies are necessary to
conﬁrm these ﬁndings.
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